Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors
Article in Cell Communication and Signaling (February 2024)
The most recent citing publications are shown below. View all 45 publications that cite this research output on Dimensions.
Gut microbiota analyses of cutaneous T-cell lymphoma patients undergoing narrowband ultraviolet B therapy reveal alterations associated with disease treatment
Article in Frontiers in Immunology (January 2024)
Class I HDAC Inhibition Leads to a Downregulation of FANCD2 and RAD51, and the Eradication of Glioblastoma Cells
Article in Journal of Personalized Medicine (August 2023)